We also are finalizing plans to begin the expansion portion of our trial, with an initial focus on patients with ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Triple-negative breast cancer accounts for 15% of all breast cancer cases ... “We have a good dose that evokes an immune ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Two cycles of dual neoadjuvant immunotherapy (nivolumab/ipilimumab or nivolumab/relatlimab) induced high pathological ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...